SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024018
Filing Date
2021-05-05
Accepted
2021-05-05 16:02:00
Documents
79
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 SRPT Q1 2021 10-Q srpt-10q_20210331.htm   iXBRL 10-Q 3330743
2 EX-31.1 srpt-ex311_10.htm EX-31.1 10534
3 EX-31.2 srpt-ex312_7.htm EX-31.2 10684
4 EX-32.1 srpt-ex321_9.htm EX-32.1 7179
5 EX-32.2 srpt-ex322_6.htm EX-32.2 7295
  Complete submission text file 0001564590-21-024018.txt   10048532

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA srpt-20210331.xsd EX-101.SCH 61858
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20210331_cal.xml EX-101.CAL 79388
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20210331_def.xml EX-101.DEF 155130
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20210331_lab.xml EX-101.LAB 409788
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20210331_pre.xml EX-101.PRE 308119
11 EXTRACTED XBRL INSTANCE DOCUMENT srpt-10q_20210331_htm.xml XML 1923147
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 21893108
SIC: 2834 Pharmaceutical Preparations